Automated description from the Alliance of Genome Resources (Release 4.0)
Is predicted to enable ribosylnicotinamide kinase activity and ribosylnicotinate kinase activity. Acts upstream of or within pyridine nucleotide biosynthetic process. Predicted to be active in cytoplasm. Is expressed in cochlea; ear; inner ear; nervous system; and vestibulo-cochlear ganglion. Orthologous to human NMRK1 (nicotinamide riboside kinase 1).